Yu-qiang Mi
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
SIRT1 rs2394445 associates with serum triacylglycerol lipidomic profile in metabolic dysfunction-associated steatotic liver disease.
Journal: Frontiers in nutrition
Published: March 20, 2026
Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram.
Journal: World journal of gastroenterology
Published: July 15, 2024
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.
Journal: World journal of gastroenterology
Published: December 24, 2023
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study.
Journal: World journal of hepatology
Published: November 21, 2023
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir.
Journal: Journal of clinical and translational hepatology
Published: February 19, 2022
The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: April 19, 2021
Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
Journal: Journal of clinical and translational hepatology
Published: February 06, 2021
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.
Journal: World journal of gastroenterology
Published: March 25, 2020
Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.
Journal: Alimentary pharmacology & therapeutics
Published: November 07, 2018
PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism.
Journal: Journal of diabetes research
Published: December 28, 2016
A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: December 05, 2016
Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Journal: International journal of molecular medicine
Published: November 24, 2016
Last Updated: 09/26/2026